The relationship between osteopenia and vascular tone disorders in mature and elderly women

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To investigate some indicators of vascular tone in women over 45 years of age with and without osteopenia for the prevention of osteoporosis.

Material and methods. 153 patients were examined, divided into 2 groups according to age: 1st (n=83) – 45–59 years old; 2nd (n=70) – 60–74 years old. Ultrasound densitometry of the calcaneal bone was performed using a FURUNO CM-200 light densitometer (Japan) with determination of the ultrasound transmission rate (SOS m/s), T-criterion. Pulse wave analysis (Multiscan BC-OXi (Russia)) was used to study microcirculation (stiffness of large arteries (SI), tone of medium and small arteries (RI), peripheral vascular resistance (PSS)).

Results. The prevalence of osteopenia in the study sample in the outpatient setting ranged from 19.2% to 38.5% between the ages of 45 and 74 years. Evaluation of microcirculation indicators in mature women depending on the presence or absence of osteopenia showed that people with osteopenia had higher PSS, SI, RI numbers. In women over 60 years of age changes in vascular stiffness and microcirculation parameters were more strongly associated with age rather than the presence of osteopenia.

Conclusions. In adulthood, women stand out as a risk group associated with the presence of osteopenia, changes in vascular stiffness and microcirculation, which requires a personalized approach to prevention. In old age, 95% of cases have increased vascular stiffness, changes in microcirculation in combination with osteopenia, which suggests active dynamic observation and treatment of concomitant cardiovascular diseases.

Full Text

Restricted Access

About the authors

D. Bazhenova

Smolensk State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: benbarnes2014@yandex.ru
ORCID iD: 0000-0003-2182-6445
SPIN-code: 6394-0456

Professor

Russian Federation, Smolensk

E. Golovanova

Smolensk State Medical University, Ministry of Health of Russia

Email: benbarnes2014@yandex.ru
ORCID iD: 0000-0003-1853-3844
SPIN-code: 1813-9950

MD, Associate Professor

Russian Federation, Smolensk

L. Lyamets

Smolensk State Medical University, Ministry of Health of Russia

Email: benbarnes2014@yandex.ru

Candidate of Engineering Sciences

Russian Federation, Smolensk

References

  1. Дедов Д.В., Марченко С.Д. Остеопороз у женщин в период постменопаузы: медико-социальное значение, профилактика переломов с помощью препаратов Остеомед и Остеомед Форте. Врач. 2022; 33 (1): 69–73 [Dedov D., Marchenko S. Osteoporosis in postmenopausal women: sociomedical significance, prevention of fractures with Osteomed and Osteomed Forte. Vrach. 2022; 33 (1): 69–73 (in Russ.)]. doi: 10.29296/25877305-2022-01-11
  2. Лесняк О.М., Баранова И.А., Белова К.Ю. и др. Остеопороз в Российской Федерации: эпидемиология, медико-социальные и экономические аспекты проблемы (обзор литературы). Травматология и ортопедия России. 2018; 24 (1): 155–68 [Lesnyak O.M., Baranova I.A., Belova K.Yu. et al. Osteoporosis in the Russian Federation: epidemiology, medical, social and economic aspects of the problem (literature review). Traumatology and orthopedics of Russia. 2018; 24 (1): 155–68 (in Russ.)]. doi: 10.21823/2311-2905-2018-24-1-155-168
  3. Майлян Э.А., Адунц А.Г., Немсадзе И.Г. и др. Распространенность и медико-социальная значимость постменопаузального остеопороза. Вестник гигиены и эпидемиологии. 2020; 24 (4): 478–85 [Maylyan E.A., Adunts A.G., Nemsadze I.G. et al. Prevalence and medical and social significance of postmenopausal osteoporosis. Vestnik of Hygiene and Epidemiology. 2020; 24 (4): 478–85 (in Russ.)].
  4. Polito A., Barnaba L., Ciarapica D. et al. Osteosarcopenia: A Narrative Review on Clinical Studies. Int J Mol Sci. 2022; 23 (10): 5591. doi: 10.3390/ijms23105591
  5. Yin Y., Tang Q., Xie M. et al. Insights into the mechanism of vascular endothelial cells on bone biology. Biosci Rep. 2021; 41 (1): 3258. doi: 10.1042/BSR20203258
  6. Gaudio A., Xourafa A., Zanoli L. et al. Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study. Sci Rep. 2020; 10 (1): 19421. doi: 10.1038/s41598-020-76427-1
  7. Le T., Salas Sanchez A., Nashawi D. et al. Diabetes and the Microvasculature of the Bone and Marrow. Curr Osteoporos Rep. 2024; 22 (1): 11–27. doi: 10.1007/s11914-023-00841-3
  8. Paolino S., Gotelli E., Goegan F. et al. Body composition and bone status in relation to microvascular damage in systemic sclerosis patients. J Endocrinol Invest. 2021; 44 (2): 255–64. doi: 10.1007/s40618-020-01234-4
  9. Комарова Ю.М. Статистика в медицине и биологии: Руководство, в 2-х томах. М.: Медицина; 2000 [Komarova, Yu. M. Statistics in Medicine and Biology: A Guide, in 2 volumes. Moscow: Medicine; 2000 (in Russ.)].
  10. Wang W., Wang Y., Tang Z. et al. Mesenchymal stem cells prevent ovariectomy-induced osteoporosis formation in mice through intraosseous vascular remodeling. Biochem Biophys Res Commun. 2021; 582: 64–71. doi: 10.1016/j.bbrc.2021.10.033
  11. Yang T.L., Shen H., Liu A. et al. A road map for understanding molecular and genetic determinants of osteoporosis. Nat Rev Endocrinol. 2020; 16 (2): 91–103. doi: 10.1038/s41574-019-0282-7
  12. Singh P., Singh M., Valecha S. et al. Investigation of eNOS gene polymorphism exposes a genetic association between endothelial dysfunction and osteoporosis in postmenopausal women. Menopause. 2020; 27 (6): 714–21. doi: 10.1097/GME.0000000000001514
  13. Колчина М.А., Скрипникова И.А., Мешков А.Н. и др. Ассоциации костной массы и полигенного риска остеопороза с показателями состояния артериальной стенки. Остеопороз и остеопатии. 2022 [Kolchina M.A., Skripnikova I.A., Meshkov A.N. et al. Associations of bone mass and polygenic risk of osteoporosis with indicators of arterial wall condition. Osteoporosis and Bone Diseases. 2022; 25 (2): 21–30 (in Russ.)]. doi: 10.14341/osteo12951
  14. Исайкина О.Ю., Скрипникова И.А., Колчина М.А. и др. Ассоциации артериальной жесткости и минеральной плотности кости у женщин в постменопаузальный период. Рациональная Фармакотерапия в Кардиологии. 2023; 19 (1): 11–6 [Isaykina O.Yu., Skripnikova I.A., Kolchina M.A. et al. Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women. Rational Pharmacotherapy in Cardiology. 2023; 19 (1): 11–6 (in Russ.)]. doi: 10.20996/1819-6446-2023-02-02
  15. Хабибулина М.М., Шамилов М.Д., Елистратов Д.Г. Эффективная фармакотерапия остеопороза в перименопаузе. Врач. 2024; 35 (11): 38–40 [Khabibulina M., Shamilov M., Elistratov D. Effective pharmacotherapy of osteoporosis in perimenopause. Vrach. 2024; 35 (11): 38–40 (in Russ.)]. doi: 10.29296/25877305-2024-11-07
  16. Шамилов М.Д., Хабибулина М.М. Остеопороз: диагностика и лечение коморбидных пациентов, персонифицированный подход к терапии. Врач. 2024; 35 (7): 24–9 [Shamilov M., Khabibulina M. Osteoporosis: diagnosis and treatment of comorbid patients, a personalized approach to therapy. Vrach. 2024; 35 (7): 24–9 (in Russ.)]. doi: 10.29296/25877305-2024-07-04
  17. Chevalley T., Brandi M.L., Cashman K.D. et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022; 34 (11): 2603–23. doi: 10.1007/s40520-022-02279-6
  18. Méndez-Sánchez L., Clark P., Winzenberg T.M. et al. Calcium and vitamin D for increasing bone mineral density in premenopausal women. Cochrane Database Syst Rev. 2023; 1 (1): CD012664. doi: 10.1002/14651858.CD012664.pub2
  19. Bertoldo F., Cianferotti L., Di Monaco M. et al. Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients. 2022; 14 (19): 4148. doi: 10.3390/nu14194148
  20. Luo C., Qin S.X., Wang Q.Y. et al. Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk. J Endocrinol Invest. 2023; 46 (2): 367–79. doi: 10.1007/s40618-022-01910-7
  21. Zaiss M.M., Jones R.M., Schett G. et al. The gut-bone axis: how bacterial metabolites bridge the distance. J Clin Invest. 2019; 29 (8): 3018–28. doi: 10.1172/JCI128521
  22. Даниленко А.П., Трунов К.С., Покровский М.В. и др. Протективная роль производных 3-оксипиридина при стероид-индуцированном остеопорозе у крыс, связанная со снижением оксидативного стресса и восстановлением образования оксида азота. Фармация и фармакология. 2023; 11 (1): 48–61 [Danilenko A.P., Trunov K.S., Pokrovsky M.V. et. al. Protective role of 3-oxypyridine derivatives in rats' steroid-induced osteoporosis associated with reduced oxidative stress and recovery of nitric oxide formation. Pharmacy & Pharmacology. 2023; 11 (1): 48–61 (in Russ.)]. DOI: 0.19163/2307-9266-2023-11-1-48-61

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Prevalence of osteopenia by age

Download (43KB)
Indexing metadata

Copyright (c) 2025 Russkiy Vrach Publishing House